Washington Post |
High prices make once-neglected 'orphan' drugs a booming business
Washington Post To make the business viable, Congress — pushed by patients and a popular television show that highlighted rare diseases — passed the Orphan Drug Act. The 1983 law offered drug companies attractive tax credits and monopolies to develop treatments for ... |
Friday, 5 August 2016
High prices make once-neglected 'orphan' drugs a booming business - Washington Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment